The Association of the British Pharmaceutical Industry (ABPI) today named Dr Richard Torbett as its new chief executive.
He replaces Mike Thompson, who has led the association as chief executive since March 2016.
Torbett, who will take over the new role in the New Year, currently serves as the organisation’s executive director of Policy. He was responsible for negotiating the 2019 Voluntary Scheme for Medicine Pricing and Access.
Before joining ABPI in July 2015, Torbett spent 14 years working across several senior roles in the pharmaceutical industry, including as chief economist at the European Federation of Pharmaceutical Industries and Associations (EFPIA) and as senior director and head of international affairs at Pfizer.
“I am delighted that Richard has been appointed as ABPI’s new chief executive. Richard is a hugely respected figure within our industry both internationally and in the UK,” said Haseeb Ahmad, ABPI President.
Torbett said: “At this critical time for our country, it’s vital that the world-leading UK life sciences industry continues to thrive. I look forward to working with all our members and partners in Government and the NHS to achieve this.”